Glycorex Transplantation AB (NGM:GTAB B) Cyclically Adjusted Book per Share: kr1.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:GTAB B Glycorex Transplantation AB NGM:GTAB B
61 GF Score
Price kr1.46
GF Value kr1.81
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Glycorex Transplantation AB Cyclically Adjusted Book per Share?

Glycorex Transplantation AB NGM:GTAB B -8.75% 61 Cyclically Adjusted Book per Share is kr1.02 as of Mar. 2026. GuruFocus rates NGM:GTAB B with a GF Score™ of 61/100 and a GF Value™ of kr1.81 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Glycorex Transplantation AB's adjusted book value per share for the three months ended in Mar. 2026 was kr0.393. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr1.02 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Glycorex Transplantation AB's average Cyclically Adjusted Book Growth Rate was -6.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Glycorex Transplantation AB was -3.90% per year. The lowest was -3.90% per year. And the median was -3.90% per year.

As of today (2026-08-05), Glycorex Transplantation AB's current stock price is kr1.46. Glycorex Transplantation AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr1.02. Glycorex Transplantation AB's Cyclically Adjusted PB Ratio of today is 1.43.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Glycorex Transplantation AB was 5.53. The lowest was 0.70. And the median was 1.74.


Glycorex Transplantation AB  (NGM:GTAB B) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Glycorex Transplantation AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.46/1.02
=1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Glycorex Transplantation AB was 5.53. The lowest was 0.70. And the median was 1.74.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Glycorex Transplantation AB Cyclically Adjusted Book per Share Related Terms


Glycorex Transplantation AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Glycorex Transplantation AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Glycorex Transplantation AB Cyclically Adjusted Book per Share Chart

Glycorex Transplantation AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.17 1.18 1.11 1.04

Glycorex Transplantation AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 1.08 1.06 1.04 1.02

NGM:GTAB B vs VRTX, REGN, RVMD: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Glycorex Transplantation AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Cyclically Adjusted PB Ratio falls into.


NGM:GTAB B
61GF Score
Glycorex Transplantation AB NGM:GTAB B
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Glycorex Transplantation AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Glycorex Transplantation AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.393/133.5600*133.5600
=0.393

Current CPI (Mar. 2026) = 133.5600.

Glycorex Transplantation AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.917 101.019 1.212
201609 0.905 101.138 1.195
201612 0.919 102.022 1.203
201703 0.920 102.022 1.204
201706 0.907 102.752 1.179
201709 0.894 103.279 1.156
201712 0.682 103.793 0.878
201803 0.710 103.962 0.912
201806 0.707 104.875 0.900
201809 0.708 105.679 0.895
201812 0.808 105.912 1.019
201903 0.846 105.886 1.067
201906 0.851 106.742 1.065
201909 0.898 107.214 1.119
201912 0.907 107.766 1.124
202003 1.402 106.563 1.757
202006 1.311 107.498 1.629
202009 1.324 107.635 1.643
202012 1.289 108.296 1.590
202103 1.217 108.360 1.500
202106 1.185 108.928 1.453
202109 1.179 110.338 1.427
202112 1.123 112.486 1.333
202203 1.067 114.825 1.241
202206 1.044 118.384 1.178
202209 1.033 122.296 1.128
202212 1.007 126.365 1.064
202303 0.948 127.042 0.997
202306 0.895 129.407 0.924
202309 0.821 130.224 0.842
202312 0.596 131.912 0.603
202403 0.549 132.205 0.555
202406 0.519 132.716 0.522
202409 0.476 132.304 0.481
202412 0.448 132.987 0.450
202503 0.494 132.825 0.497
202506 0.500 133.699 0.499
202509 0.453 133.480 0.453
202512 0.438 133.390 0.439
202603 0.393 133.560 0.393

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr1.02 mean?
Glycorex Transplantation AB (NGM:GTAB B) has a Cyclically Adjusted Book per Share of kr1.02 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Glycorex Transplantation AB and its competitors.
Is Glycorex Transplantation AB's Cyclically Adjusted Book per Share too high?
Glycorex Transplantation AB's current Cyclically Adjusted Book per Share is kr1.02. Overall, Glycorex Transplantation AB has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Glycorex Transplantation AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Glycorex Transplantation AB's Cyclically Adjusted Book per Share of kr1.02 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Glycorex Transplantation AB and its competitors. Glycorex Transplantation AB's current Cyclically Adjusted Book per Share is kr1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glycorex Transplantation AB stock overvalued right now?
Based on GuruFocus' analysis, Glycorex Transplantation AB (NGM:GTAB B) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.81, compared to a current price of kr1.46 — trading 19.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is kr1.02. Glycorex Transplantation AB's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Glycorex Transplantation AB (NGM:GTAB B), the current Cyclically Adjusted Book per Share is kr1.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Glycorex Transplantation AB (NGM:GTAB B) Overvalued in 2026?

Based on GuruFocus' analysis, Glycorex Transplantation AB stock appears to be undervalued. The current stock price of kr1.46 is trading 19.3% below its estimated GF Value™ of kr1.81. GuruFocus considers Glycorex Transplantation AB to be Modestly Undervalued.

Key valuation signals for NGM:GTAB B:

  • Cyclically Adjusted Book per Share: kr1.02
  • GF Value™: kr1.81 vs. price of kr1.46 (19.3% below fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the NGM:GTAB B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Glycorex Transplantation AB Business Description

Other Exchanges O33:Germany
Address Scheelevagen 27, Lund, SWE, 223 63
Glycorex Transplantation AB is a medical technology company. Its main product Glycosorb ABO is used clinically in six continents to facilitate blood group incompatible transplants, especially in kidney transplants from related living donors, but also in transplantation of liver, heart, lung and stem cells. Glycosorb ABO enables grafts regardless of the blood group of donors and recipients. The product is used in extracorporeal blood treatment, that is, a blood treatment that takes place outside the body in the same way as dialysis. Its segment is research, develop, manufacture, market and sell products in the field of organ transplantation or related areas. Geographically it operates in Europe, Australia, Singapore, India, and Other countries with majority of revenue from Europe.
61GF Score

Get the complete analysis for NGM:GTAB B

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.46
Price
kr1.81
GF Value